181 related articles for article (PubMed ID: 37376030)
1. Robotics and Aseptic Processing in View of Regulatory Requirements.
Tanzini A; Ruggeri M; Bianchi E; Valentino C; Vigani B; Ferrari F; Rossi S; Giberti H; Sandri G
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376030
[TBL] [Abstract][Full Text] [Related]
2. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
3. Risk analysis of sterile production plants: a new and simple, workable approach.
Gapp G; Holzknecht P
PDA J Pharm Sci Technol; 2011; 65(3):217-26. PubMed ID: 22293233
[TBL] [Abstract][Full Text] [Related]
4. Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?
Hole G; Hole AS; McFalone-Shaw I
Int J Pharm X; 2021 Dec; 3():100095. PubMed ID: 34712948
[TBL] [Abstract][Full Text] [Related]
5. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
6. Environmental Monitoring for Closed Robotic Workcells Used in Aseptic Processing: Data to Support Advanced Environmental Monitoring Strategies.
McCall J; Barnard N; Gadient K; Kasireddy C; Kurtz A; Li Y; Page T; Putnam T; Brennan Á
AAPS PharmSciTech; 2022 Aug; 23(6):215. PubMed ID: 35922577
[TBL] [Abstract][Full Text] [Related]
7. Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-839. PubMed ID: 28756845
[TBL] [Abstract][Full Text] [Related]
8. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
9. Application of Artificial Neural Networks in the Process Analytical Technology of Pharmaceutical Manufacturing-a Review.
Nagy B; Galata DL; Farkas A; Nagy ZK
AAPS J; 2022 Jun; 24(4):74. PubMed ID: 35697951
[TBL] [Abstract][Full Text] [Related]
10. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
Hock SC; Ying YM; Wah CL
PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
[TBL] [Abstract][Full Text] [Related]
11. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
[TBL] [Abstract][Full Text] [Related]
12. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
13. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
[TBL] [Abstract][Full Text] [Related]
14. Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future.
Arden NS; Fisher AC; Tyner K; Yu LX; Lee SL; Kopcha M
Int J Pharm; 2021 Jun; 602():120554. PubMed ID: 33794326
[TBL] [Abstract][Full Text] [Related]
15. PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up.
Operti MC; Bernhardt A; Grimm S; Engel A; Figdor CG; Tagit O
Int J Pharm; 2021 Aug; 605():120807. PubMed ID: 34144133
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
[TBL] [Abstract][Full Text] [Related]
17. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
[TBL] [Abstract][Full Text] [Related]
18. Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient Access.
Algorri M; Abernathy MJ; Cauchon NS; Christian TR; Lamm CF; Moore CMV
J Pharm Sci; 2022 Mar; 111(3):593-607. PubMed ID: 34478754
[TBL] [Abstract][Full Text] [Related]
19. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Manufacturing in the EU and the EU-US Mutual Recognition Agreement.
Gaspar Ernesto LM; Dias Loureiro RM
PDA J Pharm Sci Technol; 2020; 74(6):617-626. PubMed ID: 32540862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
